Freeline Therapeutics Holdings plc
FRLN
Price:
$6.49
Market Cap:
$28.28M
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in Phase 1/2 clinical trial for the treatment of Fabry disease; and FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease and is under Phase 1/2 clinical trial. In addition, it has research p...[Read more]
Industry
Biotechnology
IPO Date
2020-08-07
Stock Exchange
NASDAQ
Ticker
FRLN
The ROE as of September 2024 (TTM) for Freeline Therapeutics Holdings plc (FRLN) is -110.68%
According to Freeline Therapeutics Holdings plc’s latest financial reports and current stock price. The company's current ROE is -110.68%. This represents a change of 268.49% compared to the average of -30.04% of the last 4 quarters.
Freeline Therapeutics Holdings plc (FRLN) Historical ROE (quarterly & annually)
How has FRLN ROE performed in the past?
The mean historical ROE of Freeline Therapeutics Holdings plc over the last ten years is -106.64%. The current -110.68% ROE has changed 3.78% with respect to the historical average. Over the past ten years (40 quarters), FRLN's ROE was at its highest in in the March 2023 quarter at 2.08%. The ROE was at its lowest in in the December 2022 quarter at -43.88%.
Average
-106.64%
Median
-116.56%
Minimum
-169.75%
Maximum
-38.56%
Freeline Therapeutics Holdings plc (FRLN) ROE by Quarter and Year
Discovering the peaks and valleys of Freeline Therapeutics Holdings plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 202.30%
Maximum Annual ROE = -38.56%
Minimum Annual Increase = -56.20%
Minimum Annual ROE = -169.75%
| Year | ROE | Change |
|---|---|---|
| 2022 | -169.75% | 45.63% |
| 2021 | -116.56% | 202.30% |
| 2020 | -38.56% | -39.23% |
| 2019 | -63.46% | -56.20% |
Freeline Therapeutics Holdings plc (FRLN) Average ROE
How has FRLN ROE performed in the past?
The current ROE of Freeline Therapeutics Holdings plc (FRLN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-108.29%
5-year avg
-106.64%
10-year avg
-106.64%
Freeline Therapeutics Holdings plc (FRLN) ROE vs. Peers
How is FRLN’s ROE compared to its peers?
Freeline Therapeutics Holdings plc’s ROE is less than CNS Pharmaceuticals, Inc. (428.91%), greater than ZyVersa Therapeutics, Inc. (-172.51%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than VectivBio Holding AG (-56.92%), less than AVROBIO, Inc. (29.68%), greater than Immix Biopharma, Inc. (-86.48%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), greater than Navidea Biopharmaceuticals, Inc. (-63.06%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%),
| Company | ROE | Market cap |
|---|---|---|
| 428.91% | $4.76M | |
| -172.51% | $2.54M | |
| 2.18% | $223.46K | |
| -56.92% | $1.06B | |
| 29.68% | $5.24M | |
| -86.48% | $50.78M | |
| -328.66% | $4.06M | |
| -63.06% | $100.08K | |
| -398.33% | $4.50M |
Build a custom stock screener for Freeline Therapeutics Holdings plc (FRLN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Freeline Therapeutics Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Freeline Therapeutics Holdings plc (FRLN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Freeline Therapeutics Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Freeline Therapeutics Holdings plc's ROE?
How is the ROE calculated for Freeline Therapeutics Holdings plc (FRLN)?
What is the highest ROE for Freeline Therapeutics Holdings plc (FRLN)?
What is the 3-year average ROE for Freeline Therapeutics Holdings plc (FRLN)?
What is the 5-year average ROE for Freeline Therapeutics Holdings plc (FRLN)?
How does the current ROE for Freeline Therapeutics Holdings plc (FRLN) compare to its historical average?